Key result
Therapies for managing arrhythmias in cardiac sarcoidosis remain inadequately studied despite the condition's association with conduction block, arrhythmias, and sudden death.
This review examines the literature regarding treatments utilized to manage arrhythmias associated with cardiac sarcoidosis.
Evidence for arrhythmia therapies in cardiac sarcoidosis remains limited; leaves open optimal strategies pending dedicated prospective trials.
The prevalence of cardiac involvement in sarcoidosis is under-recognized and is associated with multiple complications, including conduction block, arrhythmias, and sudden death. The comparative roles of common therapies have been inadequately studied. The purpose of this review is to examine the literature regarding treatments utilized to manage arrhythmias associated with cardiac sarcoidosis.
No takes yet. Share an insight, caveat, or question.
Rosenthal et al. (2015) studied this question. Therapies for managing arrhythmias in cardiac sarcoidosis remain inadequately studied despite the condition's association with conduction block, arrhythmias, and sudden death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: